Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy. - Koschmieder, S; Burmeister, T; Brüggemann, M; Berkemeier, A; Volpert, S; Wieacker, P; Silling, G; Gökbuget, N; Müller-Tidow, C; Berdel, W E; Stelljes, M (Leukemia (08876924), 2014)